Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours.

Ansari N, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ.

Eur J Surg Oncol. 2016 Jul;42(7):1035-41. doi: 10.1016/j.ejso.2016.03.017. Epub 2016 Apr 9.

PMID:
27132072
2.

Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.

Sun JH, Ji ZH, Peng KW, Wu HT, Zhang Q, Yonemura Y, Li Y.

Int J Hyperthermia. 2016 May;32(3):289-97. doi: 10.3109/02656736.2016.1146802. Epub 2016 Mar 16.

PMID:
26982735
3.

Management of pseudomyxoma peritonei.

Fallis SA, Moran BJ.

J BUON. 2015 May;20 Suppl 1:S47-55. Review.

PMID:
26051332
4.

The role of cytoreductive surgery and HIPEC in epithelial ovarian cancer.

Halkia E, Spiliotis J.

J BUON. 2015 May;20 Suppl 1:S12-28. Review.

PMID:
26051328
5.

The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy.

Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A.

Colorectal Dis. 2015 Sep;17(9):772-8. doi: 10.1111/codi.12975.

PMID:
25880479
6.

Consolidation hyperthermic intraperitoneal chemotherapy and maintenance chemotherapy following laparoscopic cytoreductive surgery in the treatment of ovarian carcinoma.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown Iii JV, Wilcox AM, Goldstein BH.

Int J Hyperthermia. 2015 Feb;31(1):8-14. doi: 10.3109/02656736.2014.991766. Epub 2015 Jan 5.

PMID:
25559985
7.

The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma.

Rettenmaier MA, Mendivil AA, Abaid LN, Brown JV 3rd, Micha JP, Wilcox AM, Goldstein BH.

Arch Gynecol Obstet. 2015 Jun;291(6):1381-6. doi: 10.1007/s00404-014-3590-0. Epub 2014 Dec 17.

PMID:
25516177
8.

A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer.

Chiva LM, Gonzalez-Martin A.

Gynecol Oncol. 2015 Jan;136(1):130-5. doi: 10.1016/j.ygyno.2014.11.072. Epub 2014 Nov 28.

PMID:
25434634
9.

Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.

Spiliotis J, Halkia E, Lianos E, Kalantzi N, Grivas A, Efstathiou E, Giassas S.

Ann Surg Oncol. 2015 May;22(5):1570-5. doi: 10.1245/s10434-014-4157-9. Epub 2014 Nov 13.

PMID:
25391263
10.

Risk of definitive stoma after surgery for peritoneal malignancy in 958 patients: comparative study between complete cytoreductive surgery and maximal tumor debulking.

Riss S, Chandrakumaran K, Dayal S, Cecil TD, Mohamed F, Moran BJ.

Eur J Surg Oncol. 2015 Mar;41(3):392-5. doi: 10.1016/j.ejso.2014.09.002. Epub 2014 Sep 6.

PMID:
25238953
11.

Advances in the management of peritoneal mesothelioma.

Raza A, Huang WC, Takabe K.

World J Gastroenterol. 2014 Sep 7;20(33):11700-12. doi: 10.3748/wjg.v20.i33.11700. Review.

12.

Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Randle RW, Doud AN, Levine EA, Clark CJ, Swett KR, Shen P, Stewart JH, Votanopoulos KI.

Ann Surg Oncol. 2015 May;22(5):1634-8. doi: 10.1245/s10434-014-3987-9. Epub 2014 Aug 14.

13.

Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients.

Cascales-Campos P, Gil J, Gil E, Feliciangeli E, López V, Gonzalez AG, Ruiz-Pardo J, Nieto A, Parrilla P.

Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:88-93. doi: 10.1016/j.ejogrb.2014.05.018. Epub 2014 Jun 2.

PMID:
24965986
14.

Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin.

Järvinen P, Ristimäki A, Kantonen J, Aronen M, Huuhtanen R, Järvinen H, Lepistö A.

Int J Colorectal Dis. 2014 Aug;29(8):999-1007. doi: 10.1007/s00384-014-1933-8. Epub 2014 Jun 26.

PMID:
24965858
15.

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix.

McConnell YJ, Mack LA, Gui X, Carr NJ, Sideris L, Temple WJ, Dubé P, Chandrakumaran K, Moran BJ, Cecil TD.

Ann Surg Oncol. 2014 Jun;21(6):1975-82. doi: 10.1245/s10434-013-3469-5. Epub 2014 Jan 8.

PMID:
24398544
16.

Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.

Fagotti A, Petrillo M, Costantini B, Fanfani F, Gallotta V, Chiantera V, Turco LC, Bottoni C, Scambia G.

Gynecol Oncol. 2014 Feb;132(2):303-6. doi: 10.1016/j.ygyno.2013.12.028. Epub 2013 Dec 27.

PMID:
24378877
17.

Whole abdominopelvic radiotherapy in the palliative treatment of pseudomyxoma peritonei.

Berkovic P, van de Voorde L, De Meerleer G, Delrue L, Speleers B, Van Belle S, Vandecasteele K.

Strahlenther Onkol. 2014 Feb;190(2):223-8. doi: 10.1007/s00066-013-0470-7. Epub 2013 Dec 6.

PMID:
24306063
18.

Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.

Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, Moran BJ.

Dis Colon Rectum. 2013 Dec;56(12):1366-72. doi: 10.1097/DCR.0b013e3182a62b0d.

PMID:
24201390
19.

Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and HIPEC: preliminary results in highly selected patients.

Robella M, Vaira M, Marsanic P, Mellano A, Cinquegrana A, Sottile A, De Simone M.

Minerva Chir. 2013 Dec;68(6):551-8.

PMID:
24193287
20.

Peritoneal debulking/intraperitoneal chemotherapy-non-sarcoma.

Kelly KJ, Nash GM.

J Surg Oncol. 2014 Jan;109(1):14-22. doi: 10.1002/jso.23449. Epub 2013 Oct 24. Review.

PMID:
24166680
Items per page

Supplemental Content

Loading ...
Write to the Help Desk